Litcius/Paper detail

Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers

Michelle S. Min, Abeer Alsarheed, Bina Kassamali, Daniel R. Mazori, Morgan Schaefer, Joseph F. Merola, Gabriela Cobos, Avery LaChance, Ruth Ann Vleugels

2021Journal of the American Academy of Dermatology32 citationsDOI

Topics & Concepts

MedicineTofacitinibRefractory (planetary science)DermatomyositisDermatologyRetrospective cohort studyInternal medicineRheumatoid arthritisPhysicsAstrobiologyInflammatory Myopathies and DermatomyositisEosinophilic Disorders and SyndromesNeurogenetic and Muscular Disorders Research
Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers | Litcius